Annual Long Term Debt
$45.69 M
-$12.37 M-21.31%
31 December 2023
Summary:
Atara Biotherapeutics annual long term debt is currently $45.69 million, with the most recent change of -$12.37 million (-21.31%) on 31 December 2023. During the last 3 years, it has risen by +$32.65 million (+250.38%). ATRA annual long term debt is now -21.31% below its all-time high of $58.06 million, reached on 31 December 2022.ATRA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$35.24 M
-$3.46 M-8.94%
30 September 2024
Summary:
Atara Biotherapeutics quarterly long term debt is currently $35.24 million, with the most recent change of -$3.46 million (-8.94%) on 30 September 2024. Over the past year, it has dropped by -$13.27 million (-27.35%). ATRA quarterly long term debt is now -44.93% below its all-time high of $64.00 million, reached on 30 June 2022.ATRA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.3% | -27.4% |
| 3 y3 years | +250.4% | +43.4% |
| 5 y5 years | +100.0% | +142.5% |
ATRA Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.3% | +250.4% | -44.9% | +101.9% |
| 5 y | 5 years | -21.3% | -44.9% | +189.3% | |
| alltime | all time | -21.3% | -44.9% |
Atara Biotherapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $35.24 M(-8.9%) |
| June 2024 | - | $38.70 M(-8.3%) |
| Mar 2024 | - | $42.20 M(-7.7%) |
| Dec 2023 | $45.69 M(-21.3%) | $45.69 M(-5.8%) |
| Sept 2023 | - | $48.51 M(-6.3%) |
| June 2023 | - | $51.75 M(-5.8%) |
| Mar 2023 | - | $54.92 M(-5.4%) |
| Dec 2022 | $58.06 M(+127.5%) | $58.06 M(-4.9%) |
| Sept 2022 | - | $61.07 M(-4.6%) |
| June 2022 | - | $64.00 M(+266.7%) |
| Mar 2022 | - | $17.45 M(-31.6%) |
| Dec 2021 | $25.52 M | $25.52 M(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $24.57 M(+101.7%) |
| June 2021 | - | $12.18 M(-3.1%) |
| Mar 2021 | - | $12.57 M(-3.6%) |
| Dec 2020 | $13.04 M(-7.7%) | $13.04 M(-0.7%) |
| Sept 2020 | - | $13.13 M(-2.2%) |
| June 2020 | - | $13.42 M(-2.8%) |
| Mar 2020 | - | $13.81 M(-2.3%) |
| Dec 2019 | $14.14 M(>+9900.0%) | $14.14 M(-2.7%) |
| Sept 2019 | - | $14.53 M(-2.6%) |
| June 2019 | - | $14.92 M(+3.3%) |
| Mar 2019 | - | $14.44 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Atara Biotherapeutics annual long term debt?
- What is the all time high annual long term debt for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual long term debt year-on-year change?
- What is Atara Biotherapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly long term debt year-on-year change?
What is Atara Biotherapeutics annual long term debt?
The current annual long term debt of ATRA is $45.69 M
What is the all time high annual long term debt for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual long term debt is $58.06 M
What is Atara Biotherapeutics annual long term debt year-on-year change?
Over the past year, ATRA annual long term debt has changed by -$12.37 M (-21.31%)
What is Atara Biotherapeutics quarterly long term debt?
The current quarterly long term debt of ATRA is $35.24 M
What is the all time high quarterly long term debt for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly long term debt is $64.00 M
What is Atara Biotherapeutics quarterly long term debt year-on-year change?
Over the past year, ATRA quarterly long term debt has changed by -$13.27 M (-27.35%)